Medication info

Huriem Tablet 25/5 mg (Empagliflozin, Linagliptin)

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin Micronized›25mg / 1 tabletLinagliptin Micronized›5mg / 1 tablet
Manufacturer / importer
Huons Co., Ltd.
Appearance
Light pink, triangular, film-coated tablet with flat sides and sharp edges
Packaging
Bottle - 30 tablets/bottle, PTP - 30 tablets/box [(10 tablets/PTP X 3)]
Approval status
Active

MFDS item code 202402466 · Approved 2024.10.21

Summary

Main use
Improvement of blood glucose control in patients with type 2 diabetes
Who takes it
Adults
Adult dose
The recommended starting dose of this medicine is empagliflozin 10 mg/linagliptin 5 mg once daily. If additional glycemic control is needed and empagliflozin 10 mg/linagliptin 5 mg is tolerated, the dose of this medicine may be increased to 25/5 mg once daily. Patients switching to this medicine from concomitant therapy with empagliflozin and linagliptin should receive their existing doses. This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. However, if it is within 12 hours of your next dose, skip the missed dose and take your next dose at the usual time. Do not take a double dose in one day. Special populations Patients with renal impairment This medicine is not recommended for improving glycemic control in patients with an estimated glomerular filtration rate (eGFR) below 45 ml/min/1.73m2. No dose adjustment is required in patients with an estimated glomerular filtration rate of 45 ml/min/1.73m2 or higher. Patients with hepatic impairment No dose adjustment is required in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. Older adults No dose adjustment based on age is required. In patients aged 75 years and older, renal function and the risk of volume depletion should be considered.

Ingredients

Manufacturer
Huons Co., Ltd.

Efficacy & effects

Improvement of blood glucose control in patients with type 2 diabetes

View approved original text

This medication is used to assist in the control of blood sugar for patients with type 2 diabetes. It is particularly suited for use when taking Empagliflozin and Linagliptin together, helping to manage blood sugar effectively in conjunction with dietary and exercise therapies. By maintaining stable blood sugar levels, it aids in the treatment of diabetes.

How to take

Adult dose

The recommended starting dose of this medicine is empagliflozin 10 mg/linagliptin 5 mg once daily. If additional glycemic control is needed and empagliflozin 10 mg/linagliptin 5 mg is tolerated, the dose of this medicine may be increased to 25/5 mg once daily. Patients switching to this medicine from concomitant therapy with empagliflozin and linagliptin should receive their existing doses. This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. However, if it is within 12 hours of your next dose, skip the missed dose and take your next dose at the usual time. Do not take a double dose in one day. Special populations Patients with renal impairment This medicine is not recommended for improving glycemic control in patients with an estimated glomerular filtration rate (eGFR) below 45 ml/min/1.73m2. No dose adjustment is required in patients with an estimated glomerular filtration rate of 45 ml/min/1.73m2 or higher. Patients with hepatic impairment No dose adjustment is required in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. Older adults No dose adjustment based on age is required. In patients aged 75 years and older, renal function and the risk of volume depletion should be considered.

Precautions

This medication contains Empagliflozin and Linagliptin, and is used in the treatment of diabetes. First, individuals who are allergic to Empagliflozin, Linagliptin, or any other ingredients in this medication should not take it. Additionally, it should not be administered to patients with type 1 diabetes or diabetic ketoacidosis. Patients with significantly decreased kidney function, specifically those with a glomerular filtration rate below 30ml/min/1.73m², those with end-stage kidney disease, or those undergoing dialysis should not take this medication. In cases of mildly impaired kidney function, regular kidney function testing before and during treatment is important. Patients with mild to moderate heart failure should use this medication cautiously, and it is not recommended for patients with severe heart failure. Linagliptin may cause acute pancreatitis, so if symptoms such as severe abdominal pain occur, discontinue the medication immediately and consult a physician. Additionally, a rare but serious skin condition called bullous pemphigoid may occur, so if blisters or lesions appear on the skin, inform a doctor right away. The most common side effect during the use of this medication is urinary tract infection, which may occur more frequently in women. There is a risk of hypoglycemia when taken with other hypoglycemic agents such as insulin or sulfonylureas, so caution is needed. Decreased fluid volume or symptoms of dehydration may occur, especially in elderly patients or those with low blood pressure, so fluid status should be monitored closely. This medication can increase the risk of genital fungal infections; if related symptoms arise, appropriate treatment should be sought. Women who are pregnant or nursing are advised to avoid this medication, and should consult a physician if necessary. Safety and efficacy in children under 18 years have not been established, hence it is not recommended for this age group. In case of overdose, consult with medical personnel immediately, as there is no specific antidote, and treatment should be appropriate to the patient's condition. Lastly, this medication should be kept out of reach of children and stored in its original packaging.

Side effects

  • urinary tract infection
  • vulvovaginitis
  • vulvar inflammation
  • balanitis
  • other genital infections
  • hypersensitivity reactions
  • angioedema
  • urticaria
  • hypoglycemia
  • thirst
Show 195 more
  • ketoacidosis
  • cough
  • constipation
  • pancreatitis
  • oral ulcers
  • itching
  • rash
  • vesicular pemphigoid
  • rhabdomyolysis
  • decreased fluid volume
  • increased urination
  • dysuria
  • interstitial nephritis
  • increased amylase
  • increased lipase
  • elevated hematocrit
  • increased serum lipids
  • increased serum creatinine
  • epigastric pain
  • enterocolitis
  • intestinal obstruction
  • gastroenteritis
  • herpes zoster
  • cystitis
  • acute pyelonephritis
  • bronchitis
  • vestibular neuronitis
  • sepsis
  • pneumonia
  • decreased appetite
  • dehydration
  • hyperglycemia
  • cerebral infarction
  • stuttering
  • Alzheimer-type dementia
  • chest pain
  • fever
  • facial swelling
  • fatigue
  • death
  • chronic obstructive pulmonary disease
  • asthma
  • diabetic foot disease
  • skin lesions
  • liver metastasis
  • acute leukemia
  • basal cell carcinoma
  • non-small cell lung cancer
  • malignant pericardial effusion
  • gastric cancer
  • rectal cancer
  • pancreatic cancer
  • meniscus injury
  • pneumoconiosis
  • congestive heart failure
  • angina pectoris
  • acute myocardial infarction
  • unstable angina
  • cardiac arrest
  • diabetic retinopathy
  • acute kidney injury
  • end-stage renal disease
  • acute cholangitis
  • acute cholecystitis
  • cholangitis
  • dizziness
  • kidney transplant failure
  • constipation
  • epigastric pain
  • enterocolitis
  • intestinal obstruction
  • abdominal pain
  • gastric ulcer
  • gum bleeding
  • hemorrhoids
  • lower abdominal pain
  • diarrhea
  • vomiting
  • gastritis
  • irritable bowel syndrome
  • hyperhidrosis
  • rhinitis
  • soft tissue infection
  • pharyngitis
  • scrub typhus
  • periodontitis
  • tonsillitis
  • laryngitis
  • viral upper respiratory infection
  • tonsillitis
  • burning mouth syndrome
  • colitis
  • abdominal discomfort
  • soft tissue infection
  • appendiceal abscess
  • appendicitis
  • meningitis
  • chronic otitis media
  • peritonsillar abscess
  • pulmonary tuberculosis
  • subcutaneous abscess
  • tubo-ovarian abscess
  • vestibular neuritis
  • headache
  • intracranial aneurysm
  • vascular stent stenosis
  • vascular stent thrombosis
  • ureterolithiasis
  • acute kidney injury
  • cervical inflammation
  • nausea
  • dyspepsia
  • dizziness
  • drowsiness
  • chest discomfort
  • weakness
  • nosebleed
  • oropharyngeal pain
  • voice disorder
  • allergic rhinitis
  • exertional dyspnea
  • wet cough
  • rhinorrhea
  • pulmonary mass
  • arthralgia
  • osteoporosis
  • arthropathy
  • musculoskeletal discomfort
  • myositis
  • myalgia
  • soft tissue mass
  • postmenopausal osteoporosis
  • rotator cuff syndrome
  • astigmatism
  • allergic conjunctivitis
  • blurred vision
  • corneal erosion
  • macular fibrosis
  • eye discomfort
  • conjunctival injection
  • eyelid swelling
  • vitreous floaters
  • vitreous hemorrhage
  • epistaxis
  • exertional dyspnea
  • wet cough
  • residual phlegm
  • skin laceration
  • rib fracture
  • iliotibial band syndrome
  • palpitations
  • tachycardia
  • arteriosclerosis
  • diabetic vascular disorders
  • peripheral artery obstructive disease
  • anxiety
  • depression
  • sleep disorders
  • acute cholecystitis
  • autoimmune hepatitis
  • cholelithiasis
  • hepatitis
  • ear pain
  • positional vertigo
  • lymphadenopathy
  • hypothyroidism
  • thyroid nodule
  • vulvar pruritus
  • genital pruritus
  • hypoglycemia
  • obesity
  • hyperlipidemia
  • sebaceous cyst
  • seborrheic dermatitis
  • atopic dermatitis
  • nummular eczema
  • heat rash
  • sebaceous gland hyperplasia
  • lumbar spinal canal stenosis
  • myalgia
  • limb pain
  • musculoskeletal chest pain
  • cervical stenosis
  • fibromyalgia
  • flank pain
  • fracture pain
  • muscular weakness
  • osteoarthritis
  • diabetic retinopathy
  • dry eyes
  • cough
  • dyspnea
  • unstable angina
  • hypertension
  • insomnia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. The storage temperature should maintain room temperature between 1 degree and 30 degrees. This will help preserve the effectiveness of the medication.

Appearance and packaging

Appearance

Light pink, triangular, film-coated tablet with flat sides and sharp edges

Package unit

Bottle - 30 tablets/bottle, PTP - 30 tablets/box [(10 tablets/PTP X 3)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.